Ukrainian plasma-derived drugs producer Biofarma has doubled its planned investment in a pharmaceutical plant in Oradea, western Romania, with the first stage of the project now valued at EUR 85 million, Bihoreanul reported, cited by Economedia.ro. The Oradea project is planned in four stages, according to Biofarma representatives cited by Interfax-Ukraine. The company has not disclosed the total value of the investment, providing only the cost of bringing the first stage into operation. We have already ordered the filling line," Biofarma Plasma President Kostiantyn Yefymenko told Ukrainian media. The Oradea plant forms part of Biofarma’s expansion outside Ukraine, with the investment adding pharmaceutical production capacity in Romania.